City File: Boots strides in the right direction
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.BOOTS is expected to reveal a healthy hike in profits on Thursday from pounds 359.5m to more than pounds 400m.
The news should focus attention on the underlying strength of the group, namely its Boots the Chemists chain. Shares have been hit recently by DIY and sun-care price wars, along with scares ranging from Hillary Clinton's clampdown on drugs marketing to too much sugar in babies' bedtime drinks to the prospects for Manoplax, its heart treatment.
The figures will come after last week's deal to take space in Sainsbury's supermarkets, which was well received in the City. They will also disclose a marked fall in net debt from pounds 363m to around pounds 200m.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments